Prevalence of diabetic related foot disease in Palakkad, Kerala, INDIA

 

Asma PK¹, Muneer R E², Srikanth Putte Gowda², Pradeep Kumar KM³, Soopy Kayanaduth^3*

 

 

REFERENCES

1. Bergin SM, Brand CA, Colman PG, Campbell DA. A questionnaire for determining prevalence of diabetes related foot disease (Q-DFD): construction and validation. J Foot Ankle Res. 2009; 2:34.
2. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047–1053.
3. Melton LJI, Dyck PJ: Epidemiology: In Diabetic Neuropathy. 2^ndedition Philadelphia: W.B. Saunders; 1999.
4. Jeffcoate WJ, Harding KG: Diabetic foot ulcers. Lancet. 2003; 361 (9368):1545–1551.
5. Bennett PC, Lip GY, Silverman S, Blann, Gill PS. Validation of the Edinburgh Claudication Questionnaire in 1^st generation Black African-Caribbean and South Asian UK migrants: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.   BMC Med Res Methodol. 2011; 11:85
6. Sontheimer DL. Peripheral vascular disease: diagnosis and treatment. Am Fam Physician. 2006;73(11):1971-6.
7. Matzke S, Franckena M, Alback A, Railo M, Lepantalo M. Ankle brachial index measurements in critical leg ischaemia-the influence of experience on reproducibility.Scand J Surg. 2003; 92(2):144-147.
8. LengGC,Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version     of the WHO/Rose questionnaire for use in epidemiological surveys. JClinEpidemiol. 1992, 45(10):1101-1109.
9. Falase AO, Akinkubugbe OO. Diabetic mellitus. In: A compendium of clinical medicine. 2^ndEdition, Ibadan, Nigeria, Spectrum Books Limited; 2000: 387-408.
10. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired  leucocyte functions in diabetic patients. Diabet Med 1997; 14 (1):29-34.
11. Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64−122
12. Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med. 2004; 351(1):48-55.
13. Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo, Harrison’s Principles of Internal Medicine, 2008, 2292-2293.
14. Al-Mahroos F, Al-Roomi K. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients in Bahrain: a nationwide primary care  diabetes clinic-based study. Annals of Saudi Medicine, 2007, 27(1):25-30
15. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM.Diabetes Care. 1997;20(8):1273-8
16. Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ; AusDiab Study Group. Foot complications in Type 2 diabetes: an Australian population-based study. Diabet Med. 2003;20(2):105-13.
17. Maderal AD, Vivas AC, Zwick TG, Kirsner RS. Diabetic foot ulcers: evaluation and management. HospPract (1995). 2012; 40(3):102-15.
18. Del Brutto OH, Mera RM, King NR, Zambrano M, Sullivan LJ. The burden ofdiabetes-related foot disorders in community-dwellers living in rural Ecuador:Results of the Atahualpa Project. Foot (Edinb). 2016; 28:26-29.